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Abstract
Background: Since the rapid scale-up of antiretroviral therapy (ART) programs in sub-Saharan Africa, electronic
patient tracking systems (EPTS) have been deployed to respond to the growing demand for program monitoring,
evaluation and reporting to governments and donors. These routinely collected data are often used in
epidemiologic and operations research studies intended to improve programs. To ensure accurate reporting and
good quality for research, the reliability and completeness of data systems need to be assessed and reported. We
assessed the completeness and reliability of EPTS used in 16 HIV care and treatment clinics in Manica and Sofala
provinces of Mozambique.
Methods: We conducted a cross-sectional study to assess the completeness and reliability of key variables in the
electronic data system for patients enrolling in 16 public sector HIV treatment clinics between 1 July 2004 and 30
June 2008. Data from the electronic database was compared with data abstracted from a stratified random sample
of 520 patient charts. Percent agreement, kappa scores and concordance correlation coefficients were calculated
for specified variables. Percentile bootstrap confidence intervals were calculated to account for the stratified nature
of our sampling.
Results: A total of 16,149 patients with a median age of 33 years and a median CD4 count of 151 enrolled in
these 16 clinics between 1 July 2004 and 30 June 2008. The level of completeness was high for most variables
with height (18.6%) and weight (11.5%) having the highest amount of missing data. The level of agreement for
available data was also high with reliability statistics of 0.95 (95% CI: 0.92-0.98) for gender, 0.91 (95% CI: 0.80-1.00)
for pre-ART CD4 value and 0.97 (95% CI: 0.95-0.99) for patient retention.
Conclusions: Electronic patient tracking systems have been deployed to respond to the growing monitoring,
evaluation and reporting requirements. In our cross-sectional study of clinics in Manica and Sofala provinces of
Mozambique, we found high levels of completeness and reliability for key variables indicating that these electronic
databases provided adequate data not only for monitoring and evaluation but also for research. Routine
evaluations of the completeness and reliability of these databases need to occur to ensure high quality data are
being used for reporting and research.
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As antiretroviral treatment (ART) programs have been
rapidly scaled up in sub-Saharan Africa, electronic data
systems have been introduced to support program mon-
itoring and evaluation imperatives [1]. These data sys-
tems have facilitated the response to the growing
demands of patient management and reporting to gov-
ernments and donor groups specific for HIV care and
treatment delivery, and they rely on complete and accu-
rate charting by providers of laboratory, pharmacy and
medical visits into patient charts. They were developed
in parallel to national data systems due to the inade-
quacy of existing in-country information systems and
data collection mechanisms [1]. Typically in resource-
limited settings, program metrics for reporting are hand
calculated on a monthly basis from paper-based regis-
tries for a given health facility which are then aggregated
at the district, provincial and national-level [1,2]. Donor
agencies require information on not only the number of
persons accessing services but also estimates of patient
follow-up and retention at different points in time as
well as other performance indicators [3]. HIV care and
treatment is a chronic intervention that requires, in
addition to the typical program reporting requirements,
proper treatment and monitoring of patients over many
years. Effective delivery of HIV care and treatment over
time requires timely information on the quantity and
quality of care being provided by the workforce to
patients. These data are vital to adequately monitor site
performance and inform national planning [4].
Researchers have used electronic patient tracking
systems in epidemiologic and operations research stu-
dies of ART programs [5-10]. However, only one of
these studies provides results regarding the reliability
of data [10]. In order to use these data systems for epi-
demiologic and operations research and to ensure
accurate reporting of statistics to government agencies
and donors, the reliability and completeness of data
systems in different settings needs to be assessed and
reported.
In Manica and Sofala provinces of Mozambique, an
electronic patient trackings y s t e m( E P T S )a s s i s t e d1 8
HIV care and treatment clinics in monitoring patients’
clinical, pharmaceutical, and follow-up procedures and
in reporting aggregated performance data to government
and donor agencies. The EPTS was first implemented in
these sites, due to the length of time the clinics had
been open and the volume of patients seen, as part of a
regional roll-out of the data system. The EPTS also pro-
vides a potential source of data to assess both patient
and clinic-level characteristics within the Mozambique
public health system. We conducted a cross-sectional
study to assess the accuracy of key variables in the
EPTS compared to the source data recorded in patients’
charts and evaluated the availability of data in the EPTS
relevant to the study of patient attrition.
Methods
Study Setting
In 2007, the population totalled 1.65 million in Sofala
and 1.42 million in Manica with nearly 22% of the
population based in the capitals of Beira and Chimoio
[11]. At the end of 2009 an estimated 11.5% of Mozam-
bique’s population was infected with HIV. Central
Mozambique had one of the heaviest HIV burdens in
the country: 15.5% prevalence in Sofala; 15.3% in Man-
ica [12]. In 2003, the first ART delivery site in the two
provinces opened in Sofala’s central hospital while a sec-
ond one opened in 2004. To improve access to HIV care
and treatment, the Ministry of Health integrated ART
services into primary health care clinics distributed
throughout Manica and Sofala provinces.
HIV-infected patients who enrolled into HIV care
were assessed for ART eligibility. The initial visit
included a documentation of demographic characteris-
tics, a medical history/physical exam where patients
were clinically staged according to WHO criteria and a
blood sample was drawn for a CD4 cell count. Patients
were then determined to be eligible for ART if they had
a CD4 cell count below 200 cells/μL regardless of WHO
Stage, a CD4 count below 350 cells/μL if in WHO Stage
III or pregnant, or were in WHO Stage IV regardless of
CD4 count [13].
Once a patient was eligible for ART, the patient was
referred to a social worker for several sessions of pre-
ART counseling, and ART was subsequently initiated.
Three current first line regimens were used, each using
fixed-dose combination pills. Triomune (D4T+3TC
+NVP) was the first regimen of choice. Patients who
were concurrently being treated for Tuberculosis (TB)
were given Lamivir-S (D4T+3TC) and Efavirenz (EFV).
Patients who were pregnant were given Combivir (AZT
+3TC) and NVP [13].
After ART initiation, patients returned on a periodic
basis for clinical and laboratory monitoring and on a
monthly basis for pharmacy refills, according to national
standards [13]. Clinic-based social workers also provided
adherence support as needed. After a patient failed to
return for ART medication refill, activistas (clinic-based
peer counselors) were notified and began actively tracing
patients. The peer counselors visited the patient’sr e s i -
dence and encouraged them to return for treatment at
the clinic if the patient was still alive. If the patient had
died, the date of death was documented. These proce-
dures were standardized across all clinics included in
the study.
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(HIS) operates much like other national data systems in
the region and incorporates both paper and electronic
components. As mentioned above, paper-based registries
are utilized in health facilities to track the number of
people coming in for services on a daily basis. Specific
indicators are then tabulated on a monthly basis and
aggregated into monthly facility reports. These reports
are transferred to the district-level where the district
planning and statistics department typically enters the
monthly numbers by facility into the Ministry of
Health’s HIS, referred to as the Modulo Basico. Electro-
nic files are then sent to the provincial level where they
are pulled together and forwarded to the national level.
Attempts to evaluate the completeness, reliability and
validity of the HIS in this region are ongoing [14].
Mozambique’s HIS has not been modified to respond to
the growing need to have patient-level data systems for
HIV care and treatment.
Electronic Patient Tracking System
In Manica and Sofala provinces, HIV clinics utilized a
Microsoft Access-based EPTS containing demographic,
clinical and pharmaceutical data of patients enrolled
into the HIV care and treatment system (Table 1). The
implementation of EPTS into different clinics was a pro-
grammatic decision which factored in how long clinics
had been open (those open longer tended to be priori-
tized) and whether they had a dedicated data technician.
The database included an administrative file table con-
taining demographic variables and socioeconomic fac-
tors and a health services file table that included
pharmaceutical and clinical data. All patient-level data
were data elements in the national HIV patient medical
records and were also linkable through a unique patient
identification number.
During the initial visit for HIV-infected patients enrol-
ling into HIV care, demographic and clinical characteris-
tics were recorded in the patient charts. In addition, a
CD4 count blood specimen was sent to the laboratory,
and after processing, the results were recorded in the
patient’s chart. When a patient initiated HIV treatment
and for each subsequent pharmacy visit, the ART regi-
men, date of dispensing and next refill date were
recorded. These data were first recorded in the patient’s
chart by providers and then were entered by the data
technician into the EPTS via standardized data entry
forms after the initial visit and after each of the subse-
quent clinic and pharmacy visits.
The clinics had standardized treatment and patient
tracking protocols as all of them were managed by
Mozambique’s Ministry of Health with technical and
logistical support provided by Health Alliance Interna-
tional. Databases were maintained by data technicians,
while managers provided on-the-job training and quality
control. Data technicians were located at the health
facilities and were responsible for transcribing patient
charts into the EPTS on a real-time basis. The EPTS
had numerous range checks and cross-checks to enable
immediate detection and correction of data entry errors.
Database managers worked at the provincial-level and
monitored data quality by running queries and trouble-
shooting with technicians if discrepancies existed. The
managers circulated throughout the province to work
with each of the technicians located at health facilities.
In addition, the managers were responsible for produ-
cing quarterly, semi-annual and annual reports of pro-
gram statistics.
Study Design
To evaluate the reliability of the EPTS, we conducted a
cross-sectional study among adult (≥ 15 years of age),
ART-naïve patients receiving HIV treatment in 16 HIV
care and treatment centers between July 1, 2004 and June
30, 2008 in Manica and Sofala provinces of Mozambique.
Data from the EPTS had been previously compared to
patient chart data for two of the 18 clinics and thus these
two clinics were not included in this assessment [10]. We
compared patient-level information contained in the EPTS
with data abstracted from a total of 520 patient charts.
Stratified, random sampling was utilized to select patient
charts. Strata were defined by the clinic where patients
currently received HIV treatment, and the number of
patient charts targeted for a particular clinic depended on
the size of the patient population receiving HIV care: 20
charts for clinics with < 200 patients, 30 charts for clinics
with 200 to 499 patients and 40 charts for clinics with ≥
500 patients. A total of 520 patient charts were surveyed.
Assuming a = 0.05, a standard error of 0.0136 (based on
observed data incorporating stratified sampling), our mar-
gin of error was ± 2.67% around an expected kappa score
of 90%. Using a random list of patient identification num-
bers, trained data collectors abstracted demographic, clini-
cal and pharmaceutical data from structured patient
charts including gender, pre-ART CD4 count, date of CD4
count, first pharmacy pick-up date of antiretroviral medi-
cines at treatment initiation, retention of the patient in
HIV care and treatment (patient retention) and outcome
date as described below. Pilot testing indicated that
abstractors tended to make errors in identifying the cor-
rect pieces of information while blinded to the EPTS
values due to the complexity of patient charts. Therefore,
data abstractors were not blinded to the EPTS values.
Patient retention was defined as patients who either
remained in the program, suspended treatment per clini-
cian’s recommendation but remained in care or trans-
ferred to receive treatment at another facility. Patients
who had died or were lost to follow-up for reasons other
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gram. The patient’s outcome date was classified as the last
pharmaceutical refill date for patients who remained in
the program or who were lost to follow-up for reasons
other than death, and the date of death, suspension or
transfer was used as the outcome date for those who had
died, suspended or transferred.
In addition, we evaluated the availability of baseline
data for all adult, ART-naïve patients who initiated HIV
treatment for data commonly used in the study of attri-
tion from HIV treatment programs: age, gender, educa-
tion, weight, height, WHO stage and CD4 count
[7,8,10,15-17].
Statistical Methods
Data from the standardized patient charts were com-
pared to data contained in the EPTS. Several measures
were used to assess the extent to which the EPTS
accurately reflected the data in patients’ charts for the
sample of 520 patients. For binary variables, percent
agreement and kappa scores were generated [18]. Con-
cordance correlation coefficients were used to estimate
the degree of agreement for continuous variables [19].
For dates, we calculated the percent agreeing exactly
and the percent agreeing within 7 days of the date
recorded in the patient chart. We calculated percentile
bootstrap confidence intervals based on 1,000 replica-
tions for percent agreement, kappa scores and concor-
dance correlation coefficients. The bootstrapping
accounted for the stratified nature of our sampling for
kappa scores and concordance correlation coefficients.
To be consistent, we also used the approach for percent
agreement. All analyses were conducted in Stata version
11.1 (College Station, TX).
The study was approved by the ethical review commit-
tees of the Mozambique Ministry of Health (Comité
Table 1 Variables collected in the Electronic Patient Tracking System
Administrative Health Services
-Clinic identification number -Patient identification number
-Patient identification number -Date of visit
-Date of enrollment at HIV clinic -Type of provider seen
-Pregnancy status at time of enrollment -Pregnant at time of visit
-Number of months pregnant at enrollment -Temperature
-Age -Weight
-Gender -Height
-Site of HIV testing -CD4 count
-Date of HIV testing -CD4 percentage
-Results of HIV testing -Date of CD4 count
-City of residence -Viral load
-Neighborhood of residence -Date of viral load
-Marital status -Clinical diagnoses*
-Type of employment -WHO stage
-Years of education -CTX prophylaxis
-Type of higher education -TB prophylaxis
-Patient active at HIV clinic (yes/no) -Patient receiving ART
-Reason patient left HIV clinic -Type of ART regimen
-Date patient left HIV clinic -Type of ART refill visit
-Date the HIV clinic found out patient left -# of pills dispensed
-Exit comments -Next refill date
-ART committee date -Receiving TB treatment
-Patient receiving ART (yes/no) -Comments
-ART start date
-Type of ART initiation (new patient or transferred from another facility)
-Comments about treatment
-Pregnancy status at time of treatment initiation
-Prophylaxis for PMTCT
-Prophylaxis type
-Prophylaxis date
*includes 63 clinical diagnoses; HIV - Human Immunodeficiency Virus; ART - Antiretroviral Therapy; WHO - World Health Organization; PMTCT - Prevention of
Mother to Child Transmission; CTX - Cotrimaxazole; TB - Tuberculosis; CD4 - Cluster of Differentiation 4
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and the University of Washington Human Subjects Divi-
sion (Reference: 30410).
Results
Clinic Characteristics
A total of 16 of the 36 HIV care and treatment clinics
recognized by the Ministry of Health from Manica and
Sofala provinces were included in the analysis. Two of
the 36 clinics were included in a previous assessment,
and the remaining 18 were not included since they did
not have electronic patient tracking systems. Two of
these clinics were a vertical, stand-alone HIV care and
treatment clinics, 14 were clinics where HIV care and
treatment was integrated with primary health care ser-
vices; and one of the vertical model clinics shifted into
an integrated model. In addition, 7 (44%) of the clinics
were located in urban settings. Four (25%) were consid-
ered to be hospitals while 12 (75%) were considered to
be health centers.
Availability of Baseline Characteristics in the EPTS
The baseline characteristics of patients enrolling into
HIV treatment between 1 July 2004 and 30 June 2008
are displayed in Table 2. Overall, 16,149 adult (≥15
years of age) patients enrolled for antiretroviral therapy
in these 16 clinics with a median age of 33 years and a
median CD4 count of 151. For these patients, the level
of completeness was high for most of the variables with
WHO Stage (9.9%), weight (11.5%) and height (18.6%)
having the highest amounts of missing data. Of the 520
charts reviewed, 19 (3.7%) had missing CD4 counts and
dates in the database, 7 (1.3%) also had missing CD4
information in the patient charts.
Reliability of Data in the EPTS
A total of 520 patient charts were reviewed to evaluate
the reliability of specific variables in the electronic
patient tracking system. All of the variables had a high
level of agreement and reliability. Patient retention in
the EPTS had the highest level of agreement [99.23%
(95% CI: 98.46-99.81)] with a kappa score of 0.97 (0.95-
0.99). The date of CD4 count at treatment initiation had
the lowest level of agreement [92.61% (95% CI: 90.42-
94.61)] while 97.6% (95% CI: 96.41-98.80) agreed within
7 days of the CD4 date located in the patient’sc h a r t .
Among those records with discordant CD4 dates, the
average difference was 27.05 days with a median of 1
day (IQR: 1-10). Of clinical significance, the value of the
CD4 count at baseline also had high levels of agreement
and reliability (Table 3).
Regarding the ART initiation date of patients, 97.88%
(95% CI: 96.72-99.04) of the records agreed to the exact
day while 98.84% (95% CI: 97.88-99.61) agreed within 7
days of the date recorded in patient charts. The mean
difference for those with discrepant ART initiation dates
was 26 days with a median difference of 13 (IQR: 2-26).
The outcome date agreed 95.91% (95% CI: 94.35-97.47)
of the time while 98.05% (95% CI: 96.88-99.02) agreed
within 7 days of the date recorded in the patient’s chart.
For those patients with discordant outcome dates, the
mean difference was 14 days with a median of 7 days
(IQR: 2-17).
Discussion
Electronic patient tracking systems have evolved to
respond to the growing demands of patient management
and program reporting specific to HIV care and treat-
ment delivery. In this cross-sectional study to determine
the reliability of data within the EPTS for 16 HIV care
and treatment clinics in central Mozambique, we found
a high level of agreement between patient charts and
the EPTS. Moreover, the EPTS contained relatively
Table 2 Availability of Baseline Characteristics among
Patients Initiating HIV Treatment in the Electronic
Patient Tracking System
Patients in Treatment
N = 16,149
Missing
N (%)
Age (years), Median (IQR) 33 (27-40) 38 (0.2)
Education (years), Median (IQR) 6 (3-8) 1,194 (7.4)
Gender, N (%)
Male 6,345 (39.3) 1 (0.01)
Female 9,803 (60.7)
CD4 Count, Median (IQR) 151 (84-226) 726 (4.5)
WHO Stage, N (%)
Stage I 1,927 (11.9) 1,597 (9.9)
Stage II 2,353 (14.6)
Stage III 8,903 (55.1)
Stage IV 1,369 (8.5)
Weight (kg), Median (IQR) 50.5 (45.0-57.0) 1,857 (11.5)
Height (m), Median (IQR) 1.61 (1.56-1.68) 3,000 (18.6)
Table 3 Reliability of Data for Patients Entering HIV
Treatment in EPTS
% Agree
(95% CI)
Reliability Statistic*
(95% CI)
Gender 97.69 (96.35-98.85) 0.95 (0.92-0.98)
CD4 Value 98.40 (97.21-99.40) 0.91 (0.80-1.00)
Patient Retention† 99.23 (98.46-99.81) 0.97 (0.95-0.99)
CD4 Date 92.61 (90.42-94.61) -
ART Initiation Date 97.88 (96.72-99.04) -
Outcome Date 95.91 (94.35-97.47) -
*Kappa score for gender and patient retention; Concordance correlation
coefficient for CD4 value; No reliability statistic for date variables since they
are highly dependent on the scale of the continuous variable which is
arbitrary for date values. †As of July 2008
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for patients in antiretroviral therapy.
In another cross-sectional study of the same EPTS
conducted in two large urban hospitals in Beira and
Chimoio, Mozambique, 300 patient charts, also selected
as a stratified random sample, were reviewed to com-
pare data to that in the EPTS. Briefly, in that study the
percent agreement was 99.5% (Kappa = 0.98) for patient
gender, 91.8% (Kappa = 0.83) for provider type seen at
first visit, 97.5% for CD4 date pre-treatment initiation,
95.2% (Kappa = 0.91) for CD4 count pre-treatment
initiation, 97.5% (Kappa = 0.94) for whether a CD4
count was done 6 months post-treatment initiation and
95.7% (Kappa = 0.90) for the CD4 count 6 months post-
treatment initiation
8. These results demonstrated ‘almost
perfect’ levels of agreement in the EPTS for these 2 ver-
tical model HIV care and treatment clinics which have
the largest patient populations in Manica and Sofala
provinces. Our study also found ‘almost perfect’ levels of
agreement among a greater number of clinics which
included those clinics where HIV care and treatment
was integrated into primary health care clinics spread
throughout the two provinces [15]. In addition, our
study showed very high levels of completeness with
most variables; of the 19 (4%) CD4 counts and dates
that were missing in the EPTS, 63% of them were a
result of improper transcription from the patient charts
to the database by the data technician. However, given
that some variables had missing data, program managers
may use this information to improve recording further
through data feedback at the clinic level.
One of the limitations of our study is that we did not
randomly select variables to evaluate. We selected indi-
cators that have been emphasized by program managers
as key variables to providers and data technicians and
are frequently used in program reporting as well as epi-
demiologic and operations research studies. Appropriate
recording of patient data in charts with standardized
forms from the Ministry of Health had been highlighted
with providers as a necessary part of high quality data.
A number of important variables such as cotrimoxazole
prophylaxis as well as diagnosis and treatment of other
co-morbidities were not included in this study as pre-
vious assessments had shown that availability of these
data in the EPTS was low due, in part, to poor charting
and the unavailability of standardized forms. In addition,
our study did not have sufficient power to look at differ-
ences between clinics or clinic characteristics.
Strengths of the study include the standardization of
data recording and data assessment protocols across the
clinics included in the study. Additionally, we were able
to assess the reliability and availability of data with a
large number of clinics and this study was the largest of
its kind to date in this setting.
Our study showed that the EPTS for these 16 clinics
contained data that were relatively complete with a high
level of agreement with patients’ medical records. These
databases provide adequate data to properly monitor
patients, report to donors and governmental agencies
and conduct epidemiologic and operations research.
Future studies should focus on monitoring the availabil-
ity and accuracy of data regarding the clinical monitor-
ing process for patients (i.e. CD4 count at 6 and 12
months post treatment initiation) and be designed to
capture the potential variability between clinics.
Conclusions
The electronic patient tracking systems for HIV treat-
ment programs in Manica and Sofala provinces of
Mozambique had high levels of completeness and relia-
bility justifying their use not only for program reporting
to the Ministry of Health and donors but also for epide-
miologic and operations research. As electronic data sys-
tems are used more widely to support HIV treatment
programs, researchers should formally evaluate and
report levels of completeness and reliability of these sys-
tems to ensure that high quality data are being used for
both reporting and research. Future initiatives should
focus on both improving these systems to fill in the data
gaps and continuously monitoring the data quality.
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